Stanford tests if droperidol changes how patients like fentanyl during surgery
NCT ID NCT07015528
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study at Stanford University is testing whether the medication droperidol can change how much patients like the feeling of fentanyl, a common painkiller given during procedures. About 130 adults scheduled for surgery will receive either droperidol or a placebo, and then rate their drug liking and sedation levels. The goal is to better understand how these medications affect patient experience, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Droperidol
- What this could lead to
- If successful, this could help understand how certain medications influence feelings of drug liking in medical settings.
- What could go wrong
- This is a very early, small study focused on measuring subjective feelings, not treating a disease. Results may not lead to any practical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG LIKING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Hospital
Palo Alto, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.